of
Leptospira. The bacteria enter the human body through a breach in the skin or the mucous membrane, then into the bloodstream. The bacteria later attach to the
endothelial cells of the blood vessels and
extracellular matrix (a complex network of proteins and carbohydrates present between cells). The bacteria use their flagella to move between cell layers. They bind to cells such as
fibroblasts,
macrophages, endothelial cells, and kidney epithelial cells. They also bind to several human proteins such as complement proteins,
thrombin,
fibrinogen, and
plasminogen using surface leptospiral
immunoglobulin-like (Lig) proteins such as LigB and LipL32, whose genes are found in all pathogenic species. Through the
innate immune system, endothelial cells of the capillaries in the human body are activated by the presence of these bacteria. The endothelial cells produce
cytokines and
antimicrobial peptides against the bacteria. These products regulate the
coagulation cascade and movements of white blood cells. Macrophages presented in humans are able to
engulf Leptospira. However,
Leptospira can reside and proliferate in the
cytoplasmic matrix after being ingested by macrophages. Those with severe leptospirosis can experience a high level of cytokines such as
interleukin 6,
tumor necrosis factor alpha (TNF-α), and
interleukin 10. The high level of cytokines causes
sepsis-like symptoms, which are life-threatening instead of helping to fight against the infection. Those who have a high risk of sepsis during a leptospirosis infection are found to have the
HLA-DQ6 genotype, possibly due to
superantigen activation, which damages bodily organs.
Leptospira LPS only activates
toll-like receptor 2 (TLR2) in
monocytes in humans. The lipid A molecule of the bacteria is not recognised by human
TLR4 receptors. Therefore, the lack of
Leptospira recognition by TLR4 receptors probably contributes to the leptospirosis disease process in humans. Although various mechanisms in the human body fight against the bacteria,
Leptospira is well adapted to such an inflammatory condition created by it. In the bloodstream, it can activate host plasminogen to become
plasmin that breaks down extracellular matrix, degrades
fibrin clots and complemental proteins (
C3b and
C5) to avoid
opsonisation. It can also recruit complement regulators such as
Factor H,
C4b-binding protein, factor H-like binding protein, and
vitronectin to prevent the activation of
membrane attack complex on its surface. It also secretes
proteases to degrade complement proteins such as
C3. It can bind to thrombin, which decreases the fibrin formation. Reduced fibrin formation increases the risk of bleeding.
Leptospira also secretes
sphingomyelinase and
haemolysin that target red blood cells.
Leptospira spreads rapidly to all organs through the bloodstream. They mainly affect the liver. They invade spaces between
hepatocytes, causing apoptosis. The damaged hepatocytes and hepatocyte intercellular junctions cause bile leakage into the bloodstream, causing elevated levels of
bilirubin, resulting in jaundice. Congested
liver sinusoids and
perisinusoidal spaces have been reported. Meanwhile, in the lungs, petechiae or frank
bleeding can be found at the
alveolar septum and spaces between alveoli.
Leptospira secretes toxins that cause mild to severe kidney failure or
interstitial nephritis. The kidney failure can recover completely or lead to
atrophy and
fibrosis. Rarely, inflammation of the heart muscles, coronary arteries, and
aorta are found. ==Diagnosis==